Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
AM Best affirmed the FSR of A (Excellent) and Long-Term ICR of “a” (Excellent) for Aetna Life Insurance Company, other Aetna Health & Life Group members, Allina Health and Aetna Insurance Company, and CVS Caremark Indemnity, all with stable outlooks.
Affirmations reflect very strong balance sheet strength at Aetna Health & Life Group, improved 2025 earnings after 2024 underwriting losses, stronger Medicare Advantage Star Ratings, and continued support from parent CVS Health (NYSE: CVS), partly offset by elevated CVS financial leverage and high goodwill and intangibles.
CVS Health (NYSE: CVS) received the 2026 Newsweek AI Impact Award in the AI Health Care category for Best Outcomes – Patient Care. The honor recognizes CVS Health's AI-Driven Prescription Interpretation and Instruction Standardization technology embedded in pharmacy dispensing workflows.
The AI uses trained open-source large language models to interpret complex prescription directions and calculate precise dosage supply, helping reduce manual transcription, speed retail prescription fulfillment, and accelerate specialty pharmacy onboarding while keeping pharmacists in final clinical control.
Aetna, a CVS Health company (NYSE: CVS) introduced Aetna Mental Health On Demand, offering real-time access to licensed clinicians via chat, phone or video for members aged 13 and older. The service uses a single-session intervention model, AI-powered tools, and predictive analytics, and is slated for self-insured customers starting January 1, 2027.
During the initial launch, clinicians responded to members in about 13 seconds, aiming to improve access, support care coordination, and reduce avoidable hospitalizations through proactive outreach.
ARCTRUST Private Capital acquired a seven-property, single-tenant net lease portfolio for its planned ARCTRUST Exchange II DST, targeting 1031 exchange investors.
The portfolio totals about 51,192 square feet on 7.75 acres, spans six states, has a 13.6-year weighted average lease term, and features absolute triple-net leases with CVS Pharmacy (NYSE: CVS), Pinnacle Bank, and NAPA Auto Parts–branded locations.
Salesforce (NYSE: CRM) and CVS Health are expanding their decade-long collaboration to enhance call center care using Agentforce Health, Salesforce's AI-powered health solution.
The platform will support Aetna and CVS Caremark, serving millions of members and 1.5 million providers with faster, more personalized, data-driven interactions.
CVS Health (NYSE: CVS) is expanding GLP-1 weight management coverage through CVS Caremark’s commercial formularies. Zepbound (tirzepatide) will be reintroduced as an additional preferred option on October 1, 2026, and the new-to-market block on oral GLP-1 Foundayo (orforglipron) ends June 1, 2026, where plans approve coverage.
According to CVS Health, these formulary updates aim to improve affordability and access for plan sponsors and members via manufacturer negotiations, while maintaining plan flexibility and providing education and clinical support for smooth transitions.
Aetna, a CVS Health company (NYSE: CVS), launched the second‑generation Claims Assist Manager (CAM), an AI‑powered claims advisor platform that streamlines complex claims processing and improves payment accuracy.
CAM’s adjuster AI agents cut processing time by over 20% for manually reviewed claims and support CVS Health’s $20 billion multi‑year digital innovation investment to reduce administrative burden and enhance provider and member experience.
Glenview Capital reported on its investment in CVS Health (NYSE: CVS), noting an 80% total return on shares purchased since May 2024. After healthy Q1 results and higher annual guidance, Glenview rebalanced in May 2026, selling 3.75 million shares while keeping CVS among its three largest positions and reaffirming strong confidence in CVS’s near-, medium-, and long-term outlook.
CVS Health (NYSE:CVS) joined partners to open The Mews at St. Mary, a 75-unit senior affordable housing community in Williamstown, New Jersey.
The project is funded by a $9 million CVS investment plus HUD and NJHMFA support, and offers on-site medical, wellness, and social services for older adults.
CVS Health reports over $40 million invested in New Jersey affordable housing to date and an estimated $12.5 billion economic impact in the state in fiscal 2024.
CVS Health (NYSE: CVS) highlighted its ongoing support for service members, veterans, and military families across care, community, purpose, and economic opportunity.
Programs span TRICARE and MinuteClinic access, community partnerships, well-being initiatives, and entrepreneurship support, including $292 million in 2025 spending with veteran-owned small businesses.